Private
Several biopharmaceutical companies are working in unprecedented fashion to develop, manufacture and deliver a safe and effective vaccine to combat COVID-19 as soon as is humanly possible.
Executives from five companies developing COVID-19 vaccine candidates — AstraZeneca, Pfizer, Johnson &... Read More »
The United States was just as dangerously unprepared to combat a coronavirus pandemic in 2020 as it was back in 2015, former U.S. Sen. Joe Lieberman noted in the opening remarks of the Bipartisan Commission on Biodefense’s virtual meeting on Tuesday, setting the tone for a critical examination of... Read More »
The U.S. Food and Drug Administration (FDA) reissued an emergency use authorization (EUA) to Quest Diagnostics for its COVID-19 test.
The Quest test is the first COVID-19 diagnostic test to be authorized for use with pooled samples containing up to four individual swab specimens collected under... Read More »
Under an agreement with Pfizer Inc. and BioNTech SE, the United Kingdom will receive 30 million doses of their BNT162 mRNA-based vaccine candidate for SARS-CoV-2, expected to be delivered over the next year.
While the drug -- four vaccine candidates operating under the broader BNT162 category... Read More »
The U.S. Army has awarded FLIR Systems a $21.8 million contract to deliver its Agentase C2 spray to detect G- and V-series nerve agents, which are highly toxic chemical warfare agents.
It is a full-rate production option worth $21.8 million on an indefinite-delivery/ indefinite-quantity (IDIQ)... Read More »
Recently released study findings published in The Lancet Public Health journal has determined contact tracing speed strategies to be essential to slowing COVID-19 transmission.
Contact tracing involves tracking down all of the people who have been in contact with an infected individual so they... Read More »
While treatments for COVID-19 remain under research, Novartis announced a new initiative for low- and middle-income countries this week that will supply 15 generic and over-the-counter medicines at zero-profit as a way of treating symptoms.
The policy is only meant as a hold-over until a vaccine... Read More »
Looking to inform decision making during a pandemic, COVID-Local has created a policy mapping tool and database for communities, giving them a way to measure the effects of their COVID-19-related actions against specific policies.
COVID Analysis and Mapping of Policies is meant to identify... Read More »
The Infectious Diseases Society of America (IDSA), along with other infectious disease associations, are opposed to the Trump Administration’s decision to withdraw the United States from the World Health Organization (WHO).
The decision will weaken the nation’s ability to control the... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and the U.S. Department of Defense (DoD) announced a deal to work with Smiths Medical to expand the domestic manufacturing capacity for safety needles and syringes.
BARDA, along with the DoD’s Joint Program Executive Office for... Read More »
The COVAX Facility -- an organization created to guarantee quick and equitable access to COVID-19 vaccines throughout the world -- has garnered the interest of 75 countries and plans to support as many as 90 lower-income countries through Gavi, the Vaccine Alliance’s Advance Market Commitment... Read More »
U.S. Sen. Steve Daines (R-MT) is requesting more funding for potential COVID-19 vaccines in any new coronavirus relief package.
“As you continue your work on critical legislation to respond to the COVID-19 crisis, I write to you today to urge your support for robust funding that will help... Read More »
Sandia National Laboratories is turning to machine learning to assist COVID-19 researchers in combing through existing coronavirus studies and data.
Through a mix of algorithms, analytics, and data mining, Sandia wants to make it easy for scientists to find the data they need right at their... Read More »
Moderna, Inc. expects to begin a 30,000 participant phase 3 study of its COVID-19 vaccine candidate later this month, following the publication of an interim phase 1 analysis that demonstrated a generally safe and well-tolerated reaction among a small group of healthy adults.
The results,... Read More »
The University of Queensland’s COVID-19 vaccine candidate reached a milestone as the first participants were enrolled in its Phase 1 clinical trial.
The university’s vaccine is the seventh that is part of the portfolio of vaccines funded by the Coalition for Epidemic Preparedness... Read More »
The Johns Hopkins Applied Physics Laboratory (APL) has partnered with the Department of Homeland Security (DHS) as a means of aiding state and local governments with cyber defense efforts.
The APL and DHS’s Cybersecurity and Infrastructure Security Agency (CISA) have enlisted the assistance of... Read More »
Boeing recently announced that it has secured an Air Force contract to build the initial eight F-15EX advanced fighter jets and an overall Indefinite Delivery Indefinite Quantity pact.
Officials said the agreement calls for $1.2 billion for the first allotment of aircraft, with the overall... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) and Sichuan Clover Biopharmaceuticals, Inc. expanded their partnership last week to guarantee the rapid development and manufacturing of the company’s protein-based COVID-19 vaccine candidate.
Known as S-Trimer, the vaccine is based on... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Department of Defense penned two technology investment agreements focused on boosting domestic manufacturing last week, with Retractable Technologies, Inc. (RTI) and Becton, Dickinson and Co. (BD), respectively.
In both... Read More »
The Department of Defense (DOD) has selected Northrop Grumman Corporation’s Forward Area Air Defense Command and Control (FAAD C2) system for future Counter-Small Unmanned Aerial System (C-sUAS) procurements.
“Our FAAD C2 has been saving lives at Forward Operating Bases and locations around... Read More »
Sandia National Laboratories personnel is offering design specifications for an outdoor shelter shielding healthcare workers conducting COVID-19 testing on its licensing and technology transfer website.
The free design and instruction manual would yield a low-cost, drive-up outdoor shelter. The... Read More »
Streamlining processes this week, the National Institute of Allergy and Infectious Diseases (NIAID) created a new clinical trials network to gather thousands of volunteers together for testing of various investigational vaccines and monoclonal antibodies for use against COVID-19.
NIAID -- a part... Read More »
Pressing forward with a potential antibody treatment for COVID-19 known as REGN-COV2, the U.S. Departments of Health and Human Services (HHS) and Defense (DoD) announced an agreement with Regeneron, Inc. this week that will culminate in a commercial-scale manufacturing demonstration.
REGN-COV2... Read More »
Rewards are rolling out from the Trump administration’s Operation Warp Speed this week, including $1.6 billion -- allotted from the Departments of Health and Human Services (HHS) and Defense (DoD) -- given to Novavax, Inc. for 100 million doses of a possible COVID-19 vaccine.
While the... Read More »
A new partnership for the Biomedical Advanced Research and Development Authority’s (BARDA) ongoing efforts to grapple with COVID-19 has united it with Chembio Diagnostics, Inc. in an attempt to create a point-of-care in vitro diagnostic test.
If successful, that test would be capable of... Read More »
Emergent BioSolutions Inc. struck a five-year manufacturing services agreement with Johnson & Johnson's Janssen Pharmaceuticals Inc. for its investigational COVID-19 vaccine.
Emergent will provide contract development and manufacturing (CDMO) services for large-scale drug substance... Read More »
Smiths Detection -- a leader in threat detection and screening technologies for aviation, ports, and borders, urban security and defense -- has launched new algorithms that enhance its HI-SCAN 10080 XCT explosive-detection system (EDS) scanner’s detection capabilities.
Smiths iCMORE detection... Read More »
The National Consortium for the Study of Terrorism and Responses to Terrorism (START) has joined the RESOLVE Network, a group of individuals and organizations focused on issues related to violent extremism and community resilience.
START Director William Braniff serves on the RESOLVE Network’s... Read More »
First Responder Network Authority (FirstNet) officials recently joined a trio of agencies in presenting Accelerate R2 Network (R2 Network) Challenge awards.
The initiative serves as an interagency program connecting stakeholder response and resilience. The Department of Commerce, Economic... Read More »
Expanding on an existing partnership, the Biomedical Advanced Research and Development Authority (BARDA) and Sonica Health announced last week that they will work together to create a wearable patch capable of monitoring for COVID-19 infections.
The device is meant for high-risk clinical... Read More »
BAE Systems Applied Intelligence and Acuminor are developing new technology to help banks identify transactional behavior linked to human trafficking.
They are working on a trial with a major Nordic bank for their new solution to test the effectiveness of its financial crime detection systems.... Read More »
The U.S. Department of Health and Human Services (HHS) struck an agreement to secure large supplies of the drug remdesivir from Gilead Sciences.
HHS has secured more than 500,000 treatment courses of remdesivir -- the first authorized therapeutic for COVID-19 -- for U.S. hospitals through... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) is part of an effort to ensure equitable access to COVID-19 vaccines for all countries.
CEPI helped launch the COVID-19 Vaccine Global Access Facility (COVAX), part of the ACT Accelerator, which was established to ensure that the... Read More »
FirstNet, the broadband platform for public safety, has launched a pair of Vermont purpose-built cell sites in North Bennington and West Bridgewater.
“We worked hand-in-hand with Vermont’s public safety community to understand their needs for the network,” FirstNet Authority CEO Edward... Read More »
Scientists did not anticipate the initial threat of SARS-CoV-2, but what if they could have.
In a commentary released this month by Amesh Adalja, a senior scholar at Johns Hopkins University Center for Health Security, society could be prepared for the next pandemic through a medical... Read More »
